Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
- 1 September 2004
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (3) , 488-490
- https://doi.org/10.1016/j.jhep.2004.07.019
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *Journal of Viral Hepatitis, 2003
- Pharmacokinetics of PeginterferonsSeminars in Liver Disease, 2003
- Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis CJournal of Viral Hepatitis, 2002
- Combination of interferon induction therapy and ribavirin in chronic hepatitis CHepatology, 2001
- Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2aGastroenterology, 2001
- Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using A Mathematical ModelHepatology, 2001
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- Hepatitis C virus dynamics in vivo : Effect of ribavirin and interferon alfa on viral turnoverHepatology, 1998
- Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaHepatology, 1997